WORCESTER, Mass., Sept. 4, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, will sponsor an international diabetes symposium in Rome, Italy as an adjunct to the 44th Annual Meeting of the European Association for the Study of Diabetes taking place in Rome from September 6-11, 2008.
